Dr. Megan Harrison received her medical degree from McMaster University and completed her Pediatric residency training at Toronto’s Sick Kids Hospital. She leads many advocacy initiatives at CHEO and within the community using a strength-based, youth focused approach. Dr. Harrison’s research focuses on adolescent mothers and their children, pediatric eating disorders, vulnerable and high-risk youth, and sexual health. She thrives in collaborating with other health advocates on interdisciplinary, qualitative, arts-based research with the aim of highlighting youth voice.
The impact of COVID-19 on adolescents with eating disorders: a cohort study
Further research is required to better understand the impact of the pandemic on the clinical course and outcomes of EDs in adolescents.
Use of cyproheptadine to stimulate appetite and body weight gain: A systematic review
CY appears to be a safe, generally well-tolerated medication that has utility in helping facilitate weight gain in patients drawn from a variety of underweight populations. Future prospective randomized controlled studies in low weight patients that include objective measures of appetite and intake are needed to better understand the mechanism by which CY augments weight gain.